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ABSTRACT  
• Background 
Current multimodal approaches for the management of non-specific patellofemoral pain are not 
optimal, however, targeted intervention for subgroups could improve patient outcomes.  This study 
explores whether subgrouping of non-specific patellofemoral pain patients, using a series of low cost 
simple clinical tests, is possible. 
 
• Method 
The exclusivity and clinical importance of potential subgroups was assessed by applying à priori test 
thresholds (1 SD) from seven clinical tests in a sample of adult patients with non-specific 
patellofemoral pain. Hierarchical clustering and latent profile analysis, were used to gain additional 
insights into subgroups using data from the same clinical tests. 
 
• Results 
One hundred and thirty participants were recruited, 127 had complete data:  84 (66%) female, mean 
age 26 years (SD 5.7) and mean BMI 25.4 (SD 5.83), median (IQR) time between onset of pain and 
assessment was 24 (7-60) months.  Potential subgroups defined by the à priori test thresholds were 
not mutually exclusive and patients frequently fell into multiple subgroups.  Using hierarchical 
clustering and latent profile analysis three subgroups were identified using 6 of the 7 clinical tests. 
These subgroups were given the following nomenclature: (i) ‘strong’, (ii) ‘weak and tighter’, and (iii) 
‘weak and pronated foot’.   
• Conclusions 
We conclude that three subgroups of patellofemoral patients may exist based on the results of six 
clinical tests which are feasible to perform in routine clinical practice.  Further research is needed to 
validate these findings in other datasets and, if supported by external validation, to see if targeted 
interventions for these subgroups improve patient outcomes. 
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BACKGROUND 
Non-specific patellofemoral pain (PFP) is a musculoskeletal disorder of the knee joint that causes 
significant pain and dysfunction around the patella leading to limitations in physical activities [1].  
The condition is not  self-limiting, 90% of PFP patients still have symptoms 4 years after diagnosis 
[2,3], and only 6% are symptom free at 16 years follow up [4].   
 
PFP may be a risk factor for developing patellofemoral osteoarthritis (OA) [5, 6].  PFP has recently 
emerged as the 3rd highest ranked topic out of 185 in the Chartered Society of Physiotherapy (UK) 
Musculoskeletal Research Priority Project [7]. Expert consensus statements published following 
three International Patellofemoral Pain Research Retreats (IPFPRR) propose biomechanical risk 
factors for developing PFP described by anatomical location relative to the knee.  These factors are:  
Proximal - upper femur, hip and trunk; Local - in and around the patella and the patellofemoral joint; 
Distal - lower leg foot and ankle [8,9,10].  These risk factors may guide in developing clinical 
subgroups.  
 
Subgrouping approaches have proved fruitful to optimise management in other musculoskeletal 
conditions such as low back pain, in which psychosocial characteristics have also been incorporated 
into subgroup criteria [11, 12].  Previous authors have investigated subgroups within the PFP 
population using specialised high cost equipment not routinely seen in clinic e.g. radiographic 
examination and scintigraphy [13], dynamic MRI [14, 15], and six camera three dimensional motion 
analysis systems [16].  The translation of these results into routine practice in physiotherapy clinics is 
therefore likely to be limited.  With the exception of Dierks et al [16] the focus of these studies has 
tended to be on local biomechanical factors, rather than adopting an holistic approach that also 
incorporates proximal and distal factors.   
 
Recently Selhorst et al [17] reported on a pilot study of 21 paediatric PFP patients, mean age 14 
years, where they defined a new PFP classification algorithm that contains four subgroups; elevated 
fear avoidance, decreased muscle flexibility, functional malalignment, decreased muscle strength. 
Unfortunately they provided no details are as to how the 4 groups were derived. Keays, Mason and 
Newcombe [18] also described four clinical PFP subgroups; hypermobility, hypomobility, faulty 
movement pattern, osteoarthritis. Interestingly they had a very wide age range in their sample from 
13-82 years with only eight patients in the 20-40 year age range and each participant was required 
to have four X-rays of the knee.  With the exception of gender [19] the main focus of most previous 
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studies of PFP has been on biomechanical rather than non-biomechanical factors [20]. Selhorst et al 
[17] highlight the necessity of addressing psychosocial factors in PFP and there is some evidence to 
suggest a relationship exists between patients with PFP and activity levels [8], weight [6], and pain 
mechanisms [21], these factors may be of relevance to subgrouping approaches in the management 
of patients suffering from PFP. 
   
The present study is part of a larger programme of work exploring whether targeted management of 
PFP subgroups can optimise patient outcome.   Previously, seven clinical assessment tests have been 
proposed that may be useful in identifying clinical subgroups [22].  Further detail on these clinical 
assessment tests and à priori test thresholds can be found in the protocol for this study [22].  
In the present paper, we aimed to explore whether subgrouping of patellofemoral pain patients, 
using a series of low cost simple clinical tests, was possible.  Four objectives were identified: 
(1) to determine the relative frequency with which the patients fell into each of the potential 
subgroups defined by the à priori test thresholds;  
(2) to assess whether the potential subgroups defined by the à priori test thresholds  were 
mutually exclusive or whether, and how frequently, patients fell into two or more 
subgroups;  
(3) to ascertain whether other approaches such as hierarchical clustering and latent profile 
analysis, offered additional insights into subgrouping of PFP patients using data from the 
same clinical assessment tests; 
(4) to report differences in patient-related characteristics (demographic, clinical and 
psychosocial) across subgroups. 
 
METHODS 
Design of the clinical study  
A cross-sectional observational study design was used. Participants attended an assessment clinic on 
one occasion prior to physiotherapy treatment, at which a physiotherapist undertook the seven 
clinical assessment tests (Table 1). In addition, an assessment of demographic (e.g. age, gender and 
anthropometry), clinical (e.g. skin temperature index, time since onset), and psychosocial 
characteristics (e.g. physical activity, function, quality of life and pain levels) was completed (Table 
2). No formal power calculation was undertaken given the exploratory nature of the study but a 
target sample of 150 was considered sufficient to estimate the proportion of participants who fell 
into different subgroups and for multiple group membership, with adequate precision [22]. 
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The setting and type of participants  
Four National Health Service (NHS) physiotherapy clinics, serving the general population, 
participated in this study; one in primary care, three in hospital settings. Between May 2012 and 
November 2013, patients aged between 18 and 40 years diagnosed with non-specific unilateral or 
bilateral PFP were approached to participate in this study (Figure 1).  Eligibility criteria were based 
on criteria used in two previous studies [23, 24] where patients with specific pathologies such as 
ligamentous instability or patella subluxation were excluded, these are fully detailed in the protocol 
for this study [22].  Patients were included in this study if the duration of their pain was at least 3 
months and they self-reported anterior or retropatellar pain on at least two of the following 
activities: prolonged sitting, ascending or descending stairs, squatting, running, kneeling, and 
hopping/jumping.  Two of the following on clinical examination were also required: pain during 
resisted isometric quadriceps contraction, pain on palpation of the posterior facets of the patella, 
pain during squatting.  When eligible patients agreed to participate, written informed consent was 
obtained. 
Clinical assessment  
There were seven clinical assessment tests 1) passive prone knee flexion (rectus femoris length), 2) 
passive knee extension in supine (hamstrings length), 3) calf flexibility standing method 
(gastrocnemius length) measured using inclinometry, 4) Hip abductor strength, 5) quadriceps 
strength measured using hand-held dynamometry, 6) Total patellar mobility (medial plus lateral 
glide) measured using the patellar glide test, and 7) foot pronation assessed by the Foot Posture 
Index (FPI).  In the presence of bilateral PFP pain, assessment was undertaken on the most affected 
leg, as nominated by the patient. To ensure standardisation across the study centres, all therapists 
attended an initial, and three refresher, training days and were provided with a manual outlining the 
assessment procedures. Each site was visited by members of the research team (JS, JJ) on at least 3 
occasions to monitor fidelity with assessment procedures.   
 
Statistical methods 
For each measure of muscle flexibility, the mean of three assessments, reported in degrees from the 
baseline position, was taken as the test score.  For both measures of muscle strength, the maximum 
moment measured in Newton-metre (Nm) from 3 trials was taken as the test score.  This was also 
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normalised to body mass, that is, Newton-metre per kilogram (Nm/Kg).  For patellar mobility the 
total medial/lateral displacement in millimetres of the distal pole was taken as the test score.  For 
the seven clinical assessment tests, and patient demographic, clinical, psychosocial and functional 
characteristics, summaries are presented using mean (SD), median (inter-quartile range) or 
frequency (%), as appropriate. 
 
In this paper we report the findings of an exploratory analysis of the membership of predetermined 
subgroups using two approaches.  Firstly the data were explored using à priori test thresholds, based 
on 1 SD from published norms (Table 3).  The lower limb biarticular muscle tightness subgroup was 
defined by lack of flexibility in two of the three clinical assessment tests.  For quadriceps and hip 
abductor muscle weakness subgroups, the test score was in Nm because of the lack of available 
population data normalised for weight.   Percentages of participants falling into individual subgroups 
and into multiple subgroups were estimated, with 95%CIs calculated using exact binomial methods.  
Sensitivity analysis was undertaken using different standard deviations from the published 
population norms (1.5 SD, 2.0 SD, 2.5 SD).   
 
Secondly the data were explored using two other approaches; hierarchical agglomerative cluster 
analysis (using SPSS) and latent profile analysis (using Latent Gold). Hierarchical agglomerative 
cluster analysis, a bottom-up approach to partitioning participants into subgroups based on the 
similarity (or distance) of the set of variables (e.g. clinical tests or measures), and latent profile 
analysis, a statistical method of estimating the probability of individuals’ membership of latent (or 
unknown) classes (or subgroups) based on a set of variables (e.g. clinical tests or measures), in which 
it is assumed that the variables are independent, given the class membership.   For the hierarchical 
agglomerative cluster analysis, Ward’s method was used, Euclidean distance squared and 
standardised the data using the Z-scores.  The number of subgroups was based on the number which 
could be supported within a clinical context [25].   
 For latent profile analysis, Akaike information criterion (AIC) and Bayesian information criterion 
(BIC) were computed for each model to aid the choice of model and hence the number of subgroups 
[26].  Both methods, hierarchical clustering and latent profile analysis were performed 
independently and parallel to each other by two separate authors of this paper.  In these analyses 
data were used from each flexibility test separately and strength normalised for body mass (Nm/kg). 
The mean and standard deviation of test scores are reported for each subgroup in each approach 
and analysis of variance (ANOVA) was performed to test for significant differences in individual test 
scores between the groups.  The differences between means of other patient characteristics were 
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also explored using ANOVA.  In both sets of ANOVAs, when overall differences were statistically 
significant (p<0.05), multiple comparisons between subgroups were performed using Tukey’s B 
(Wholly Significant Difference) test [27]; if observed subgroup variances differed substantially, the 
sensitivity to the equal variances assumption was assessed by also performing the Games-Howell 
test [28].  Comparisons between subgroups for gender and activity were made using 2-tests, with 
pairwise multiple comparisons using Bonferroni correction of P-values when overall differences were 
statistically significant (P<0.05).  
 
Approvals, consent and licenses 
The study received ethical approval from NRES Committee North West – Greater Manchester North, 
REC reference: 11/NW/0814 and University of Central Lancashire (UCLan) Built, Sport and Health 
(BuSH) Ethics Committee Reference Number: BuSH 025. R&D approval was also obtained from each 
participating NHS trust and licenses for the questionnaire instruments obtained, where required.   
 
RESULTS 
One hundred and thirty participants were recruited, three participants did not have a complete set 
of seven clinical test scores and were removed from further analyses (table 1). The study cohort was 
predominantly female and on average was slightly overweight, the mean age was 26 years (SD 5.7) 
(Table 2).  
Table 1. Mean (sd) for the 7 clinical tests for 127 participants 
 
 
Clinical 
assessment 
tests  
 
 
 
 
 
Rectus Femoris Length test 0   
Hamstring Length test 0 
Gastrocnemius Length test 0 
 
Maximum Quadriceps Strength Nm 
Maximum Quadriceps Strength normalised to body 
mass Nm/kg 
 
Maximum Hip Abductor Strength Nm 
Maximum Hip Abductor Strength normalised to body 
weight Nm/kg 
 
Total Patellar Mobility mm 
 
Foot Posture index 
 
129.4 (20.05) 
151.4 (14.77) 
27.8 (10.75) 
 
73.7 (41.13) 
1.0   (0.51) 
 
 
72.8 (38.85) 
1.0 (0.50) 
 
 
12.2 (4.63) 
 
4.4  (4.44) 
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Table 2.  Patient-related (demographic, clinical and psychosocial) characteristics for 127 participants 
 
Demographic 
characteristics 
 
 
 
Mean (SD) age in years 
Number (%) of females 
Mean (SD) Height in m 
Mean (SD) Body Mass in kg 
Mean (SD) Body mass index in kg/m2 
26     (5.7) 
84   (66%) 
1.7 (0.11) 
73.5 (18.3) 
25.4 (5.83) 
 
Clinical 
characteristics 
Median (IQR) time since clinical onset in months*** 
Number (%) with Bilateral pain  
Number (%) with traumatic onset** 
Mean (SD) patellar temperature index (Celsius) $ * 
 
24 (7 to 60) 
67 (52.8%) 
17 (13.4%) 
4.7 (3.55) 
 
Psychosocial  
characteristics 
 
 
 
 
Mean (SD) Numerical Pain Rating Scale* 
Mean (SD) Self-completed Leeds Assessment of 
Neuropathic Symptoms and Signs pain scale 
(SLANSS)*** 
Mean (SD) Short-form McGill Pain Questionnaire  
      Continuous pain 
      Intermittent pain 
      Neuropathic pain 
      Affective descriptors 
Number  (%) with low physical activity level – (IPAQ) 
**** 
Mean (SD) Modified Functional Index Questionnaire* 
Mean (SD) Hopkins Symptom Checklist 
Mean (SD) EQ-5D-5L 
       Index value* 
       Visual Analogue Scale (VAS) 
Mean (SD) WHO Disability Assessment Scale II*** 
Mean (SD) Movement Specific Reinvestment Scale  
        Movement self-consciousness subscale 
        Conscious motor processing subscale    
4.7  (1.95) 
6.5  (5.84) 
 
 
 
3.1  (1.95) 
2.4   (2.02) 
0.8   (1.15) 
1.2   (1.76) 
19   (15.0%) 
34.1 (16.97) 
1.3   (0.42) 
 
0.7  (0.17) 
75.4 (16.56) 
19.4   (7.04) 
 
13.3 (6.69) 
17.4 (5.75) 
 
$ Difference in skin temperature between the patella and anterior tibialis;* 1 missing value;** 2 
missing values; *** 3 missing values; **** 6 missing values 
No participant met the à priori criteria for hypermobility, few for lower limb biarticular muscle 
tightness (27.6%, 95%CI  20.0% to 36.2%) or foot pronation (33.9%, 95%CI  25.7% to 42.8%) but most 
met the criteria for quadriceps weakness (98.4%, 95% CI 94.4% to 99.8%), patellar hypomobility 
(96.1%, 95% CI 91.1% to 98.7%) and hip abductor weakness (88.2%, 95% CI 81.3% to 93.2%).  
Consequently, most participants (89.8%, 95% CI 83.1% to 94.4%) met the criteria for at least 3 
subgroups: 40.2% fell into 3 subgroups; 44.1% into 4 subgroups and 5.5% into 5 subgroups (figure 2). 
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Even when the most extreme values of 2.5 SD was considered, only 38.6% (n=49) fell into just one 
subgroup.     
 
 
Table 3.  Distribution of 127 participants into predetermined subgroups using different SD from 
population norms 
  
  
  
  
 Standard deviation from published population norm 
Published population 
norm 
1 SD 1.5 SD  2 SD 2.5 SD 
Mean (sd)    n (%)   n (%)  n (%)   n (%) 
Lower limb 
biarticular 
tightness 
 
35 (27.6%) 12 (9.4%) 8 (6.3%) 3 (2.4%) 
Quadriceps 132.21 (16.39) 33 (30.0%) 19 (15.5%) 12 (9.4%) 3 (2.4%) 
Hamstrings 
Male: 
142.55 (6.85) 
Female: 
153.66 (11.13) 
 
31 (24.4%) 18 (14.2%) 9 (7.1%) 4 (3.1%) 
Gastrocnemius 35.22 (6.59) 74 (58.3%) 46 (36.2%) 38 (29.1%) 24 (18.9%) 
Hip abductor 
weakness 
Male: 
Age<30: 185 (37.6) 
Age≥30: 163 (37.4) 
Female: 
Age<30: 114 (31.8) 
Age≥30: 102 (26.0) 
 
112 (88.2%) 100 (78.7%) 66 (52.0%) 38 (29.9%) 
Quadriceps 
weakness 
Male: 
Age<30: 242 (55.8) 
Age≥30: 236 (43.8) 
Female: 
Age<30: 160 (26.4) 
Age≥30: 157 (41.9) 
 
125 (98.4%) 119 (93.7%) 115 (90.6%) 104 (81.9%) 
Patellar 
hypomobility 
26.2 (5.8) 122 (96.1%) 111 (87.4%) 89 (70.1%) 63 (49.6%) 
Patellar 
hypermobility 
26.2 (5.8) 0 0 0 0 
Foot pronation 4 (3) 43 (33.9%) 18 (14.2%) 17 (13.4%) 3 (2.4%) 
No subgroup  0 1 (0.8%) 2 (1.6%) 7 (5.5%) 
 
Preliminary analysis of both hierarchical cluster and latent profile analysis, showed a similar mean 
hamstring length across subgroups, therefore this variable was excluded from the final analyses for 
11 
 
both approaches. For the latent profile analysis approach, the AIC and BIC suggested either a 3 or 5 
cluster solution as the best fit to the data.  Three subgroups were chosen, as this would be more 
feasible to implement in practice and partitioning into 5 subgroups did not offer any further insight 
into potential treatment regimens.  
  
Both classification methods, hierarchical clustering and latent profile analysis, generated subgroups 
which, on interpretation of the mean test scores across the six clinical assessments, could be given 
the same nomenclature (table 4) : there was a ‘strong’ subgroup, a ‘weak and tighter’ subgroup, and 
a ‘weak and pronated foot’ subgroup.  In both methods, the ‘strong’ subgroup exhibited the highest 
mean quadriceps and hip abductor strength with the most flexible rectus femoris and subgroup 
membership was highly consistent.  The ‘weak and tighter’ subgroup, exhibited weak mean 
quadriceps and hip abductor strength and were less flexible (in one of the two assessments).  The 
‘weak and pronated foot’ subgroup exhibited the highest mean FPI, and in the hierarchical clustering 
method, this was also accompanied by the greatest patellar mobility.   However, only about half of 
the participants were consistently classified across the hierarchical cluster and latent profile analysis 
methods for these two subgroups (table 5).   
 
Table 4. Mean test scores across the 3 subgroups generated by hierarchical cluster and latent profile 
analysis  
Subgroup WEAK and 
TIGHTER 
     Mean (SD) 
STRONG 
Mean (SD) 
WEAK and 
PRONATED FOOT 
     Mean (SD) 
ANOVA 
Hierarchical  clustering N=49 
 
N=29 
 
N=49 
 
 
 Rectus Femoris Length0 121.8 (19.48) 140.7 (17.06)** 130.4 (19.21) 
 
F=9.26 
P <0.001 
Gastrocnemius Length0 22.3 (9.71)* 28.0 (6.51)* 33.1 (11.21)* 
 
F=14.98 
p<0.001 
Quadriceps Strength 
Nm/kg 
0.84 (0.32) 1.65 (0.53)** 0.82 (0.32) F=53.01 
p<0.001 
Abductor Strength 
Nm/kg 
0.79 (0.30) 1.69 (0.46)** 0.83 (0.29) 
 
F=75.11 
p<0.001 
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Total Patellar Mobility  
mm 
10.0 (3.55) 10.8 (3.03) 15.4 (4.61)** F=27.12 
p<0.001 
Foot Posture index 3.3 (4.16) 3.0 (5.28) 6.3 (3.49)** F=8.22 
p<0.001 
Latent profile analysis  N=50 
 
 N=28 
 
 N=49 
 
 
 Rectus Femoris Length0 119.1 (18.06)** 140.6 (16.91) 133.5 (18.99) F=14.58, 
p<0.001 
Gastrocnemius Length0 28.7 (11.08) 28.2 (6.29) 26.6 (12.39) F=0.53, 
p=0.59 
Quadriceps Strength 
Nm/kg 
0.62 (0.24)* 1.68 (0.52)* 1.04 (0.23)* F=97.54, 
p<0.001 
Abductor Strength 
Nm/kg 
0.60 (0.18)* 1.73 (0.42)* 1.02 (0.21)* F=167.69, 
p<0.001 
Total Patellar Mobility mm 12.5 (3.77 10.5 (3.15) 12.8 (5.84) F=2.55, 
p=0.083 
Foot Posture index 2.80 (4.35) 3.71 (5.33) 6.37 (3.11)** F=9.51, 
p<0.001 
*  all groups significantly different from each other (p<0.05) 
** group significantly different from each of the other two (p<0.05) 
 
Table 5: Comparison of subgroup membership between the two classification methods 
Subgroups generated by    Latent profile analysis Total 
 
 
Hierarchical 
cluster  
 analysis 
 ‘Weak and tight’ ‘Strong’ ‘Weak and 
pronated foot’ 
 
‘Weak and 
tighter’ 
25   1 23 49 
‘Strong’ 
 
 1 26 2 29 
‘Weak and 
pronated foot’ 
24  1 24 49 
total  50 28 49 127 
 
Table 6 shows the comparison of other patient related factors across the three subgroups generated 
by each of the methods.  The ‘strong’ subgroup had more males, lower BMI and higher levels of 
physical activity; they also exhibited lower pain scores with significantly lower SLANSS; function as 
measured by the MFIQ was significantly better than the ‘weak and tight’ subgroup when classified 
by the latent profile analysis, and there was a trend towards better quality of life compared to the 
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other subgroups. The ‘weak and tighter’ subgroup had significantly higher BMI and worse MFIQ 
scores when classified by the latent profile analysis, and there was a trend towards low physical 
activity and longer duration of PFP, when classified by the hierarchical cluster analysis. The ‘weak 
and pronated foot’ subgroup was significantly younger at time of first assessment and had the 
shortest duration since the onset of their PFP according to both classification methods. 
 
Table 6. Patient-related factors distributed across the 3 subgroups generated by the hierarchical 
cluster and latent profile analysis 
Subgroup WEAK and TIGHTER 
 
 
Mean (SD) 
 
STRONG 
 
 
Mean (SD) 
 
WEAK and 
PRONATED FOOT 
 
Mean (SD) 
Test statistic and P-value 
Hierarchical cluster 
analysis  
N=49 
 
N=29 
 
N=49 
 
 
Age 26.9 (5.34) 28.3   (6.15)** 24.9 (5.36)** F=3.85,p=0.024 
Gender (% male)   13 (26.5%)  17  (53.6%)* 13 (26.5%) 2 = 10.29, p=0.006 
BMI 25.8 (5.37) 23.5 (4.44) 26.2 (6.77) F=2.12, p=0.12 
Physical activity level 
(low) 
  10 (20.8%)   2 (6.9%) 7 (15.2%) 2 = 2.69, p=0.26 
Movement specific 
reinvestment scale 
31.4 (11.33) 29.0  (12.50) 30.9 (10.66) F=0.418, p=0.66 
Time from onset 58.0 (63.77) 45.2  (57.5) 34.1. (43.15) F=2.22, P=0.11 
HSCL (depression)   1.3   (0.38)   1.3   (0.57)   1.3    (0.36) F=0.066, P=0.94 
Pain (NPRS)   5.2 ( 1.88)   4.1   (1.68)   4.5    (2.08) F=2.84, P=0.062 
SLANSS (total)   8.1 (5.85)**   4.4   (5.58)**   6.1    (5.62) F=3.98, P=0.021 
EQ-5D-5L VAS 75.9 (14.40) 77.9 (17.23) 73.5  (18.22) F=0.67, P=0.52 
WHO Disability 
Assessment Scale II 
20.9 (7.27) 17.5   (8.27) 19.2    (5.70) F=2.24, P=0.11 
 Modified Functional 
Index Questionnaire 
37.0 (16.99) 28.0 (15.45) 35.0 (17.21) F=2.72 P=0.070 
 
Latent profile 
analysis 
 
    N=50 
 
       N=28 
  
    N=49 
 
Age 27.1 (5.56) 28.1 (5.99)** 24.8  (5.26)** F=3.74, p=0.026 
Gender (% male)   8 (16.0%)** 17   (60.7%)** 18   (36.7%) 2=16.32, p<0.001 
BMI 28.3 (6.81)* 23.2 (4.60) 23.7  (3.89) F=12.24, p<0.001 
Physical activity level 
(low) 
  8 (16.7%)   2 (7.1%)   9   (19.1%) 2=2.03, p=0.36 
Movement specific 
reinvestment scale 
30.6 (10.89) 28.6 (12.34) 31.9 (11.18) F=0.77, p=0.47 
Time from onset 46.7 (54.67) 47.2 (57.70) 44.5 (56.93) F=0.03, p=0.97 
HSCL (depression)   1.3   (0.37)   1.23 (0.45)   1.3   (0.46) F=0.21, p=0.81 
Pain (NPRS)   5.0   (2.03)   4.14 (1.76)   4.6   (1.93) F=1.96, p=0.15 
SLANSS (total)   6.5   (5.36)   4.14 (5.62)**   7.8   (6.11)** F=3.56, p=0.031 
EQ-5D-5L VAS 72.3 (18.54) 80.4 (15.61) 75.8 (14.40) F=2.18, p=0.12 
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 WHO Disability 
Assessment Scale II 
20.4   (6.59) 16.8   (8.05) 20.0   (6.60) F=2.59, p=0.079 
Modified Functional 
Index Questionnaire 
38.1 (16.98)** 28.3 (16.52)** 33.5 (16.46) F=3.18, p=0.045 
  *different from each of the other two subgroups (p<0.05) 
** subgroup pairs different (p<0.05)  
 
 
DISCUSSION 
The present findings suggest that three subgroups of PFP patients may be identified using six low 
cost, simple clinical assessment, tests that can be applied in routine practice.  This study provides an 
important first step in deducing whether targeted intervention for patients with PFP may be a useful 
strategy that ultimately leads to improved outcomes for patients.   Previous work on subgrouping 
has mostly focussed on using imaging techniques [13, 14, 15, 16] rather than on clinical testing; the 
small number of studies which have had a greater clinical focus have been small scale with a total of 
just 71 patients across two studies [17, 18] these may be underpowered to detect subgroups.   
Although it was anticipated that separate subgroups would be identified by each of the clinical 
assessment tests, this was not the case.  In part, this may be because of inadequately defined á 
priori diagnostic thresholds available in the literature, but even applying more extreme thresholds 
suggested most participants fell into more than one predetermined subgroup (Table 3).  Multiple 
predetermined subgroup membership was confirmed by hierarchical cluster and latent profile 
analysis, which generated three novel subgroups based on a combination of test scores.  A ‘strong’ 
subgroup had the highest hip abductor and quadriceps strength mean scores and greatest rectus 
femoris length, while a ‘weak and tighter’ group had low mean scores for hip abductor and 
quadriceps strength and evidence of less flexibility,  Although the ‘weak and pronated foot’ 
subgroup appeared to be reliant on the results of just the FPI in the latent profile analysis, greater 
patellar mobility additionally appeared to be an important factor in the hierarchical cluster analysis 
(Table 4).   Using different populations to that reported in this paper previous researchers [17, 18] 
have proposed four rather than three clinical subgroups of PFP patients.  However, in common with 
the results reported here both previous papers describe a tight or hypomobile group that included 
measurements of rectus femoris and gastrocnemius length.  Both previous papers also describe a 
weak group where weakness in the quadriceps and hip muscles were identified by a combination of 
visual inspection and functional testing rather than through specific objective testing using 
dynamometry.  It is interesting to note that three independent studies performed in different 
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countries USA [17], Australia [18], and the UK, each with a slightly different PFP population and each 
using slightly different methods have reported some consistency in subgroups of PFP patients.    
 
Therapist fidelity to the assessment process was high with only 3 patients with incomplete clinical 
assessments.  This suggests that the assessments were feasible in practice within both primary and 
tertiary care physiotherapy clinics.   Exploratory analyses also suggested that clinical assessment test 
scores of hamstring length are not informative in terms of subgrouping.   From a clinical perspective 
these results are very interesting as hamstring stretching is often a component of physiotherapy 
treatment regimens for PFP.  While hamstring tightness does not appear to be an important factor 
for subgrouping in PFP, our results compared to normative data found tight hamstrings in 24.4% 
(n=31) participants indicating that some patients may benefit from treatment.  The research 
therapists conducting the tests found the assessment of quadriceps strength easier than the hip 
abductor measurement and we test scores were moderately highly correlated (r=0.72), so further 
investigation of the ‘added value’ of performing both tests is merited.  Further work to identify the 
optimal thresholds for individual and combined clinical assessment tests which best classify PFP 
participants into the three novel subgroups is currently being undertaken.  This work could 
potentially reduce the burden of assessment by reducing the number of tests required. 
 
 Other measures were included to assess patient characteristics such as the Hopkins Symptom 
Checklist and the Movement Specific Reinvestment Scale.  However, these tests did not seem to 
contribute significantly to our understanding of subgroups or were difficult to administer e.g. the 
Short-form McGill Pain Questionnaire, so we propose to exclude these tests in future studies of 
subgrouping PFP patients.  WHODAS II scores were moderately highly correlated (Spearman’s r = -
0.68) with the EQ-5D-5L, which has become firmly established as the ‘gold standard’ quality-of-life 
outcome measure for musculoskeletal physiotherapy practice in the UK [29], so on this basis we 
would also exclude the WHODAS II from further studies.  
 
The baseline characteristics of the participants suggest that the study population was representative 
of PFP patients attending physiotherapy clinics [23, 30, 31].  The ratio of females to males was 2 to 1, 
a high proportion had bilateral pain (53%), and only a small percentage (13.8%) of patients reported 
a traumatic onset of pain.  While the BMI profile of this cohort might be higher than expected for 
athletes with PFP, it was still lower than that of the UK general population and reflects that this was 
a general clinical population [32]. Mean clinical assessment test scores were also consistent with 
published findings for PFP patients [33-35].  Across the whole sample, pain scores were relatively 
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low, and function scores, levels of physical activity and quality-of-life scores were relatively good, as 
might be expected for what is considered a relatively low grade bothersome musculoskeletal 
condition.  There were marked differences in the relative frequency of men and women across the 
subgroups.  Although overall there were about twice as many women as men in the study 
population, there were relatively more men in the ‘strong’ group.  While this observation might be 
considered inevitable because females tend to have lower muscle strength than males, about half or 
4 in 10 were women in this subgroup, dependent on the method used (table 6). Analysis suggested 
that subgroups were stable for female participants but the number of males were too small for 
further analysis (data not shown).  Further research should focus on potential differences in 
characteristics between subgroups and on investigating whether there are differences in subgroups 
between genders.  
 
There were also differences between the subgroups with respect to some of the other participant 
characteristics.  While it is not possible from this cross-sectional study to identify the direction of the 
relationship between the test scores and these other characteristics, they may provide further 
insights into aetiology or sequelae, which could guide further research on preventative strategies or 
therapeutic management.  The ‘weak and tighter’ subgroup, generated by latent class analysis, had 
significantly higher mean BMI, with the majority being overweight and lowest physical activity, when 
subgroups were generated by the hierarchical approach.  Being overweight has been associated with 
patellar cartilage loss [36, 37]. The speculated relationship between patellofemoral pain and 
patellofemoral osteoarthritis and the known relationship between obesity and knee osteoarthritis 
suggests that this observation is worthy of further investigation [6].  Whether the development of 
patellofemoral OA is potentially greater in this group compared to other two groups is at this stage 
highly speculative.   In the short term it might however, point towards the need for adjunct 
strategies to promote activity and encourage weight loss in this subgroup, in addition to 
strengthening and flexibility exercises.   While lower limb muscle weakness in PFP patients is well 
known, it was more surprising that a ‘strong’ subgroup existed with a trend towards less pain, higher 
function and better quality of life.  This might suggest that the other well-known observation in PFP 
patients, that of poor neuromuscular control, is important and interventions focussing on movement 
control are required [38, 39].  The significantly younger age of the ‘weak and pronated foot’ group is 
interesting but initial suggestions of a developmental issue, are tempered by us specifically 
recruiting over 18 year olds to minimise the chance of ‘growth spurt’ problems.  Other studies have 
demonstrated higher levels of passive ankle dorsiflexion in adolescents with knee pain [40] and this 
might suggest strategies including foot orthoses are warranted specifically for this subgroup.   
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Limitations 
This was not an efficacy trial and there are no outcome data following treatment. Therefore it is 
unclear whether using the 3 subgroups suggested by this study will have any impact on modifying 
clinical practice or more importantly on improving patient outcomes. We considered that we needed 
at least 150 participants but recruited 130 of which 127 had sufficient data to be included in the 
exploratory analyses.  Recruitment had to close because of time constraints.  Although the target 
sample size was not reached, confidence intervals for subgroups based on a priori thresholds are 
relatively precise and similar subgroups across hierarchical cluster and latent profile analysis have 
been generated.  However given the small number of men in the sample, we could not confirm that 
subgroupings are similar in different genders.  Additionally the study focussed specifically on the 
young adult population aged 18-40, so it is unknown if these subgroups are relevant to adolescents 
or older patients. 
 
There are a myriad of different approaches for subgrouping data and these will tend to give different 
results for the same dataset [25].  We chose to explore the data using two different approaches to 
provide some internal validation.  We were to some extent reassured that generated subgroups 
could be given the same nomenclature. However, there were important differences in participant 
characteristics and the mean test scores between the groups.  This makes clinical interpretation 
difficult. The two approaches differ in how they generate subgroups with latent profile analysis 
splitting the sample into smaller groups whereas hierarchical agglomerative clustering has a bottom-
up approach. Also, latent profile analysis differs from cluster analysis methods in that individuals are 
not assigned definitively to classes based on a chosen distance measure but are typically assigned to 
classes based on probabilities of membership of each class, usually estimated via maximum-
likelihood estimation of the parameters of a specified model. Unlike cluster analysis, there is no 
requirement to explicitly scale each variable as the classification is based directly on the 
distributional properties of the variables and classifications are therefore unaffected by the choice of 
a variable’s scale.  Because of these features, latent profile analysis is increasingly considered a 
better analytical approach to hierarchical clustering methods [40].  It also provides information on 
the most likely number of clusters (by using the AIC and BIC), whereas this is more difficult to assess 
in hierarchical clustering methods.  However, hierarchical clustering may more closely reflect clinical 
decision-making where test scores are assessed sequentially to build up a picture of the main 
problem of the patient.   Further validation of the subgroups using other datasets is required which 
would also provide further information on the relevance of patellar mobility and other patient 
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characteristics. Furthermore, it will be important to determine if the optimising treatments based on 
subgroups will improve patient outcomes. 
 
SUMMARY & CONCLUSIONS 
Three subgroups of patients with PFP have emerged based on six clinical assessment tests.  A 
‘strong’ subgroup had the greatest rectus femoris length, lowest pain scores, significantly more 
males, better function and better quality-of-life and were the oldest.  A ‘weak and tighter’ subgroup 
had significantly higher BMI, MFIQ and SLANSS with a trend towards lower physical activity levels 
and the longest duration of PFP.  A ‘weak and pronated foot’ subgroup had the greatest patellar 
mobility, was significantly younger at time of first assessment and had the shortest duration of PFP.  
The study suggests that the six assessment procedures are feasible for therapists in primary care and 
hospital settings to perform in routine practice.  We propose to undertake further work to validate 
these subgroups using external datasets, to examine optimal thresholds to assign participants to 
groups and, to assess whether more targeted intervention, based on these subgroups, would 
improve patient compliance and outcome, and as a result be more cost-effective.  
 
 
What are the new findings 
 Three subgroups of patellofemoral patients have been identified 
 The subgroups are: ‘strong’; ‘weak and tighter’; ‘weak and pronated’ 
 6 simple low cost clinical tests can be used to identify the subgroups 
 
How might it impact on clinical practice in the near future 
 Targeted intervention based on these subgroups may improve patient outcomes 
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